Kangmei Pharma | 600518 - 流动负债

金融业

CNY

CNY 13.31B

现金及等价物

CNY 1.23B

CNY 841.45M

CNY 6.8B

CNY 5.38B

CNY 173.71M

CNY -12.72M

CNY -12.72M

6.37K

EPS每股收益

CNY 0

股本和储备

CNY 7.31B

CNY 238.34M

债务利息支出

CNY 1.82M

CNY 2.44M

CNY 68.57M

CNY 20.93B

CNY -16.56M

CNY 1.09B

CNY -10.94M

普通股股本

CNY 13.83B

1.11K

CNY -14.01M

CNY 1.08B

销售和管理费用

CNY 237.06M

CNY 2.38B

贸易债权人

CNY 2.46B

应收帐款人

CNY 2.92B

	流动负债	更改		日
Akebia Therapeutics	USD 173.88M		10.95M	2026-03
Alaunos Therapeutics	USD 595K		218K	2026-03
Avita Medical	AUD 62.68M		77K	2025-12
Cspc Pharmaceutical	CNY 10.18B		65.36M	2025-12
Dianthus Therapeutics	USD 38.28M		7.55M	2026-03
Genomma Lab Internacional	MXN 7.65B		418.99M	2026-03
Hypermarcas	BRL 4.11B		849.68M	2025-12
Ionis Pharmaceuticals	USD 717M		66M	2026-03
IQVIA Holdings	USD 8.33B		9M	2026-03
Jiangsu Hengrui	CNY 5.64B		732.51M	2026-03
Kangmei Pharma	CNY 5.38B		433.79M	2026-03
Moderna	USD 2.4B		408M	2026-03
Organon & Co	USD 2.5B		110M	2026-03
Revvity	USD 1.24B		92.6M	2026-03
Sh Fosun Pharma	CNY 36.58B		156.4M	2026-03
Tectonic Therapeutic	USD 12.96M		3.29M	2026-03
Viatris	USD 6.81B		284M	2026-03
Wuxi Apptec	CNY 19.04B		193.78M	2026-03
Xeris Pharmaceuticals	USD 118.59M		9.02M	2026-03
Zz Pientze Pharmaceu	CNY 2.28B		134.52M	2026-03